UNCY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Impact · against what's priced in

The news is neutral to slightly negative as it merely reminds investors of a legal deadline for a lawsuit stemming from a known 39.1% stock price crash in June. The core catalysts—the second FDA CRL and the existence of the class action—are already reflected in the current valuation.

UNCY−0.10

No priced-in read yet